Family Medicine · Nederland, TX
NPI
1942301130
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2400 Highway 365, Suite 201
Nederland, TX, 77627
Phone (409) 833-9797
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
2,425 services
Medicare patients, 2024
211
Average age 74
Drug cost, 2024
$2.5M
24,366 prescriptions
Company payments, 2025
$602
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary J Castro was code 36415 (venipuncture blood collection), 227 times for 147 patients. In total Mary J Castro billed 2,425 services in 49 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 227 | 147 | $8.65 | $1,964 |
| 99214 Office E&M - Established | Office | 220 | 152 | $79.69 | $18K |
| 80053 Clinical Chemistry | Office | 197 | 135 | $10.16 | $2,002 |
| 80061 Clinical Chemistry | Office | 194 | 133 | $12.94 | $2,510 |
| 85025 Blood Count | Office | 188 | 138 | $7.46 | $1,403 |
| 81015 Clinical Chemistry | Office | 90 | 74 | $2.96 | $266 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 82 | 82 | $121.47 | $9,960 |
| 81003 Clinical Chemistry | Office | 64 | 52 | $2.14 | $137 |
| 83036 Blood Count | Office | 60 | 52 | $9.38 | $563 |
| 99213 Office E&M - Established | Office | 52 | 48 | $44.69 | $2,324 |
| 96372 Injection Administration | Office | 26 | 19 | $9.78 | $254 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 25 | 13 | $30.75 | $769 |
| 99308 SNF E&M | Office | 18 | 16 | $55.36 | $996 |
| 82043 Clinical Chemistry | Office | 17 | 17 | $5.36 | $91.18 |
| 82570 Clinical Chemistry | Office | 17 | 17 | $4.81 | $81.84 |
By year: 2022 $71K for 2,742 services; 2023 $56K for 2,149 services; 2024 $45K for 2,425 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 227 | 147 | $8.65 | $1,964 |
| 80053 Clinical Chemistry | 197 | 135 | $10.16 | $2,002 |
| 80061 Clinical Chemistry | 194 | 133 | $12.94 | $2,510 |
| 85025 Blood Count | 188 | 138 | $7.46 | $1,403 |
| 81015 Clinical Chemistry | 90 | 74 | $2.96 | $266 |
| 81003 Clinical Chemistry | 64 | 52 | $2.14 | $137 |
| 83036 Blood Count | 60 | 52 | $9.38 | $563 |
| 82043 Clinical Chemistry | 17 | 17 | $5.36 | $91.18 |
| 82570 Clinical Chemistry | 17 | 17 | $4.81 | $81.84 |
Medicare prescription drug claims, 2024
In 2024, the drug Mary J Castro prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,071 prescriptions and refills. In total Mary J Castro wrote 24,366 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,071 | 2,807 | 324 | $9,160 |
| Amlodipine Besylate Generic | 861 | 2,264 | 263 | $4,764 |
| Levothyroxine Sodium Generic | 832 | 2,132 | 226 | $6,161 |
| Lovastatin Generic | 738 | 1,959 | 220 | $5,700 |
| Losartan Potassium Generic | 684 | 1,814 | 213 | $6,416 |
| Gabapentin Generic | 655 | 1,285 | 191 | $11K |
| Omeprazole Generic | 561 | 1,421 | 182 | $6,318 |
| Metformin Hcl Generic | 556 | 1,445 | 180 | $2,633 |
| Lisinopril Generic | 505 | 1,285 | 152 | $3,186 |
| Pantoprazole Sodium Generic | 454 | 1,165 | 153 | $4,201 |
| Rosuvastatin Calcium Generic | 448 | 1,272 | 157 | $5,363 |
| Montelukast Sodium Generic | 390 | 988 | 122 | $4,382 |
| Hydrochlorothiazide Generic | 374 | 991 | 120 | $1,481 |
| Ozempic Semaglutide | 367 | 457 | 72 | $411K |
| Gemtesa Vibegron | 341 | 373 | 32 | $107K |
Brand drugs: 3,823 claims; generic drugs: 20,323 claims; opioid claims: 445.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary J Castro $602 ($602 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $179.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $179 |
| Abbvie Inc. ABBV | 12 | $138 |
| Novo Nordisk Inc NVO | 5 | $92.97 |
| Lundbeck LLC | 2 | $57.79 |
| Inspire Medical Systems, Inc. INSP | 1 | $33.27 |
| Axsome Therapeutics, Inc. AXSM | 1 | $24.7 |
| Lilly USA, LLC LLY | 1 | $24.62 |
| GlaxoSmithKline, LLC. GSK | 1 | $18.83 |
| Pfizer Inc. PFE | 1 | $16.92 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $16.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.